Cargando…
Drug management of autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease is the most common genetic kidney disease affecting adults. Approximately 60% of patients develop kidney failure by 60 years of age due to slowly expanding kidney cysts. A healthy lifestyle and rigorous control of blood pressure slow kidney cyst growth. T...
Autores principales: | Theivendran, Thiveya, Ramachandran, Alister, Rangan, Gopi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
NPS MedicineWise
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9584797/ https://www.ncbi.nlm.nih.gov/pubmed/36382165 http://dx.doi.org/10.18773/austprescr.2022.052 |
Ejemplares similares
-
Developments in the management of autosomal dominant polycystic
kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008) -
Is serum copeptin a modifiable biomarker in autosomal dominant polycystic kidney disease?
por: Tasneem, Moomal, et al.
Publicado: (2018) -
Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022) -
Management of autosomal-dominant polycystic kidney disease—state-of-the-art
por: Müller, Roman-Ulrich, et al.
Publicado: (2018) -
Effect of Reducing Ataxia-Telangiectasia Mutated (ATM) in Experimental Autosomal Dominant Polycystic Kidney Disease
por: Zhang, Jennifer Q. J., et al.
Publicado: (2021)